Clinical Trial Update: Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating repurposing metformin as a leukemia-preventive drug for clonal hematopoiesis with CCUS and low-risk myelodysplasti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Clonal Cytopenias of Undetermined Significance
• Myelodysplastic Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Kirsten Grønbæk | Conditions: Preleukemia, Myelodysplastic Neoplasm | Phase 2 | Status: RECRUITING